Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Steve, Aldington"'
Publikováno v:
on behalf of the EMERALD Study Group 2022, ' Patients views on a new surveillance pathway involving allied non-medical staff for people with treated diabetic macular oedema and proliferative diabetic retinopathy ', Eye . https://doi.org/10.1038/s41433-022-02050-1
Background/Objective To explore acceptability by patients and health care professionals of a new surveillance pathway for people with previously treated and stable diabetic macular oedema (DMO) and/or proliferative diabetic retinopathy (PDR). Subject
Publikováno v:
EMERALD Study Group 2021, ' Surveillance of people with previously successfully treated diabetic macular oedema and proliferative diabetic retinopathy by trained ophthalmic graders: cost analysis from the EMERALD study ', British Journal of Ophthalmology . https://doi.org/10.1136/bjophthalmol-2021-318816
Background/aimsSurveillance of people with previously successfully treated diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) adds pressure on ophthalmology services. This study evaluated a new surveillance pathway entailing m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4e37fd25964de35e3e3aa6503040c36
https://pure.qub.ac.uk/en/publications/surveillance-of-people-with-previously-successfully-treated-diabetic-macular-oedema-and-proliferative-diabetic-retinopathy-by-trained-ophthalmic-graders-cost-analysis-from-the-emerald-study(067f3ed2-fc53-4764-beee-975089ae5827).html
https://pure.qub.ac.uk/en/publications/surveillance-of-people-with-previously-successfully-treated-diabetic-macular-oedema-and-proliferative-diabetic-retinopathy-by-trained-ophthalmic-graders-cost-analysis-from-the-emerald-study(067f3ed2-fc53-4764-beee-975089ae5827).html
Autor:
Steve Aldington
Publikováno v:
Diabetic Medicine. 36:1319-1319
Autor:
Bart Keymeulen, Trevor Orchard, Selcuk Dagdelen, Ivan I. Dedov, Veronique Kerlan, Steve Aldington, Massimo Porta, Ronald Klein, Peter Rossing
Publikováno v:
Sjølie, A K, Klein, R, Porta, M, Orchard, T, Fuller, J, Parving, H H, Bilous, R, Chaturvedi, N & Bek, T 2008, ' Effect of Candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomized placebo-controlled trial ', Lancet, vol. 18, no. 372, pp. 1385-93 .
Aarhus University
Sjølie, A K, Klein, R, Porta, M, Orchard, T, Fuller, J, Parving, H H, Bilous, R & Chaturvedi, N 2008, ' Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2) : a randomised placebo-controlled trial ', Lancet, vol. 372, no. 9647, pp. 1385-1393 . https://doi.org/10.1016/S0140-6736(08)61411-7
Aarhus University
Sjølie, A K, Klein, R, Porta, M, Orchard, T, Fuller, J, Parving, H H, Bilous, R & Chaturvedi, N 2008, ' Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2) : a randomised placebo-controlled trial ', Lancet, vol. 372, no. 9647, pp. 1385-1393 . https://doi.org/10.1016/S0140-6736(08)61411-7
Summary Background Diabetic retinopathy remains a leading cause of visual loss in people of working age. We examined whether candesartan treatment could slow the progression and, secondly, induce regression of retinopathy in people with type 2 diabet
Autor:
Anne Katrin Sjølie, Judith Stephenson, Steve Aldington, Eva Kohner, Hans Janka, Lynda Stevens, John Fuller, B. Karamanos, C. Tountas, A. Kofinis, K. Petrou, N. Katsilambros, M. Cignarelli, R. Giorgino, M.L. De Geco, I. Ramunni, C. Ionescu-Tirgoviste, C.M. Iosif, C. Pitei, S. Buligescu, G. Tamas, Z. Kerenyi, A.M. Ahmed, J. Toth, P. Kempler, S. Muntoni, M. Songini, M. Stabilini, M. Fossarello, S. Pintus, B. Ferriss, C.C. Cronin, M. Toeller, A. Klischan, T. Forst, F.A. Gries, R. Rottiers, H. Priem, P. Ebeling, M. Sinisalo, V.A. Koivisto, B. Idzior-Walus, B. Solnica, L. Szopinska-Ciba, K. Solnica, H.M.J. Krans, H.H.P.J. Lemkes, J.J. Jansen, J. Nunes-Cornea, J. Boavida, G. Michel, R. Wirion, A.J.M. Boulton, H. Ashe, D.J.S. Fernando, G. Pozza, G. Slaviero, G. Comi, B. Fattor, F. Bandello, H. Mehnert, A. Nuber, H. Janka, D. Ben Soussan, M.C. Fallas, P. Fallas, E. Jepson, S. McHardy-Young, J.H. Fuller, D.J. Betteridge, M. Milne, G. Crepaldi, R. Nosadini, G. Cathelineau, B. Villatte Cathelineau, M. Jellal, N. Grodner, P. Gervais Feiss, F. Santeusanio, G. Rosi, M.R.M. Ventura, C. Cagini, C. Marino, R. Navalesi, G. Penno, R. Miccoli, M. Nannipieri, S. Manfredi, G. Ghirlanda, P. Cotroneo, A. Manto, C. Teodonio, A. Minnella, J.D. Ward, S. Tesfaye, C. Mody, C. Rudd, G.M. Molinatti, F. Vitelli, M. Porta, G.F. Pagano, P. Cavallo Perin, P. Estivi, R. Sivieri, Q. Carta, G. Petraroli, N. Papazoglou, G. Manes, G. Triantaphyllou, A. Ioannides, M. Muggeo, V. Cacciatori, F. Bellavere, P. Galante, M.L. Gemma, K. Irsigler, H. Abrahamian, C. Gurdet, B. Hornlein, C. Willinger, S. Walford, E.V. Wardle, G. Roglic, Z. Resman, Z. Metelko, Z. Skrabalo
Publikováno v:
Ophthalmology. 104:252-260
Purpose: To assess the frequency of retinopathy and vision loss in patients with insulin-dependent diabetes mellitus and their relations to potentially modifiable risk factors. Methods: The authors conducted a multicenter cross-sectional study of dia
Autor:
Gojka Roglic, Coen Stehouwer, Maria Isabel Ferreira de Sousa, Francesco Giorgino, Marco Songini, Monica Nannipieri, Casper G Schalkwijk, Anna Casu, Carlo Cagini, Steve Aldington, Jose Boavida
Publikováno v:
European Journal of Endocrinology, 166(2), 325-332. BioScientifica Ltd.
Context and objectiveHigh-mobility group box-1 (HMGB1) is a pro-inflammatory cytokine that may contribute to the pathogenesis of micro- and macrovascular complications commonly observed in diabetes. We investigated whether HMGB1 is associated with: i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f455a844996bd128b6f1499dedb8939
https://cris.maastrichtuniversity.nl/en/publications/37207e90-bdb2-4e7e-b1b6-a26e23e55dbc
https://cris.maastrichtuniversity.nl/en/publications/37207e90-bdb2-4e7e-b1b6-a26e23e55dbc
Autor:
Gojka Roglic, Francesco Giorgino, Marco Songini, Monica Nannipieri, Anna Casu, Carlo Cagini, Steve Aldington, Jose Boavida, Danielle Schoenaker
Publikováno v:
Diabetologia
Diabetologia, 55(8), 2132-2141
Diabetologia 55 (2012) 8
Diabetologia, 55(8), 2132-2141
Diabetologia 55 (2012) 8
Aims/hypothesis Low adherence to recommendations for dietary saturated fatty acid (SFA) and fibre intake in patients with type 1 diabetes mellitus may heighten their increased risk of cardiovascular disease (CVD) and mortality. We examined the relati
Autor:
Sern Lim, Philip Böhme, Michel Marre, David Hopkins, Paul Glasziou, Alice Stanton, Severine Bompoint, John Chalmers, Christopher J Nolan, Basel Al Aloul, Nikolai Petrovsky, Simon Heller, Rohina Joshi, Peter Minárik, Karen R Mullan, Gillian Whalley, Andre Pascal Kengne, Beata Czerwieńska, Mark Woodward, Bryan Williams, Ronald Stolk, Rafał Ficek, Vivek Chaturvedi, Bruce Neal, Hapizah Nawawi, Stephen Harrap, Stephen MacMahon, Dorairaj Prabhakaran, Steve Aldington, Anushka Patel, Anthony Rodgers, Laurent Billot, Lakshmy Ramakrishnan
Publikováno v:
New England Journal of Medicine, 358(24), 2560-2572. MASSACHUSETTS MEDICAL SOC
The New England Journal of Medicine, 358, 24, pp. 2560-72
The New England Journal of Medicine, 358, 2560-72
The New England Journal of Medicine, 358, 24, pp. 2560-72
The New England Journal of Medicine, 358, 2560-72
Contains fulltext : 69678.pdf (Publisher’s version ) (Open Access) BACKGROUND: In patients with type 2 diabetes, the effects of intensive glucose control on vascular outcomes remain uncertain. METHODS: We randomly assigned 11,140 patients with type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ce4e1a498158492903c91b2579b570
https://research.rug.nl/en/publications/45d3c122-ca8b-499f-b4aa-30a919db6cc6
https://research.rug.nl/en/publications/45d3c122-ca8b-499f-b4aa-30a919db6cc6
Autor:
Ole, Hejlesen, Bernhard, Ege, Karl-Hans, Englmeier, Steve, Aldington, Leo, McCanna, Toke, Bek
Publikováno v:
Studies in health technology and informatics. 107(Pt 1)
The primary aim of TOSCA-Imaging, which was a part of the TOSCA Project financed by EU's Fifth Framework IST Programme, was to develop Internet based software and image data bases for screening and diagnosis of diabetic retinopathy and implementing i
Autor:
L. K. Stevens, A. K. Sjølie, J. H. Fuller, Eva M. Kohner, Judith Stephenson, Steve Aldington, H. Janka
Publikováno v:
Vision Research. 35:S214